Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?

Is the 308 polymorphism in the tumor necrosis factor (alpha) (TNF alpha) promoter region a marker of disease susceptibility in European patients with primary sclerosing cholangitis (PSC)?

Bibliographic Details
Main Authors:	Mitchell, SA, Spurkland, A, Boberg, K, Chapman, R, Fleming, K, Schrumpf, E, Cholangit, E
Format:	Journal article
Published:	1998

Similar Items

Association of the tumour necrosis factor alpha -308 but not the interleukin 10 -627 promoter polymorphism with genetic susceptibility to primary sclerosing cholangitis.
by: Mitchell, SA, et al.
Published: (2001)

Tumour necrosis factor alpha (TNF) gene haplotypes and primary sclerosing cholangitis
by: Cullen, SN, et al.
Published: (2003)

New time dependent prognostic models for primary sclerosing cholangitis (PSC)
by: Rocca, G, et al.
Published: (2000)

Patients with small duct primary sclerosing cholangitis have favorable long term prognosis.
by: Bjornsson, E, et al.
Published: (2001)

PRODUCTION OF INTERFERON-ALPHA BY LIVER AND PERIPHERAL-BLOOD T-LYMPHOCYTES IN PRIMARY SCLEROSING CHOLANGITIS
by: Martins, E, et al.
Published: (1995)

Prognostic indicators of primary sclerosing cholangitis determined by a cox phase-specific time-dependent model.
by: Boberg, K, et al.
Published: (1998)

HLA class II haplotypes in primary sclerosing cholangitis patients from five ethnic groups.
by: Saarinen, S, et al.
Published: (1998)

ADHESION MOLECULE EXPRESSION IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Bloom, S, et al.
Published: (1992)

TISSUE DISTRIBUTION OF AN AUTOANTIGEN SPECIFIC FOR PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Lo, S, et al.
Published: (1992)

Deposition of complement C9 in primary sclerosing cholangitis (PSC).
by: Shanahan, J, et al.
Published: (1998)

Natural history of primary sclerosing cholangitis. A longterm follow-up study of 394 European primary sclerosing cholangitis patients
by: Boberg, K, et al.
Published: (2000)

Enhanced cytokine mRNA expression in Primary Sclerosing Cholangitis (PSC) and autoimmune liver diseases.
by: Mitchell, S, et al.
Published: (1997)

The HLA-DR3,DQ2 heterozygous genotype is associated with an accelerated progression of primary sclerosing cholangitis.
by: Boberg, K, et al.
Published: (2001)

IMMUNOGENETIC FACTORS IN THE CLINICAL COURSE OF PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Mehal, W, et al.
Published: (1993)

Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis.
by: Björnsson, E, et al.
Published: (2002)

Cytokine profiles in primary sclerosing cholangitis (PSC) and autoimmune liver diseases: Comparing expression in the periphery and the liver.
by: Mitchell, SA, et al.
Published: (1997)

Detection of antineutrophil cytoplasmic antibody in primary sclerosing cholangitis: Comparison of the alkaline phosphatase and immunofluorescent techniques.
by: Bansi, D, et al.
Published: (1996)

DETECTION OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY IN PRIMARY SCLEROSING CHOLANGITIS - COMPARISON OF THE ALKALINE-PHOSPHATASE AND IMMUNOFLUORESCENT TECHNIQUES
by: Bansi, D, et al.
Published: (1995)

Cholangiocarcinoma in primary sclerosing cholangitis is associated with long-standing inflammatory bowel disease. A long-term follow-up of 394 primary sclerosing cholangitis patients.
by: Boberg, K, et al.
Published: (2001)

Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation.
by: Boberg, K, et al.
Published: (2002)

INAPPROPRIATE EXPRESSION OF BLOOD-GROUP ANTIGENS ON THE BILIARY EPITHELIUM IN PRIMARY SCLEROSING CHOLANGITIS (PSC)
by: Bloom, S, et al.
Published: (1990)

HLA class II haplotypes in primary sclerosing cholangitis patients from five European populations.
by: Spurkland, A, et al.
Published: (1999)

Liver cell proliferation in primary sclerosing cholangitis (PSC), as assessed by anti-KI-67 labelling.
by: Shanahan, J, et al.
Published: (1998)

Down regulation of interferon gamma and up regulation of interleukin-10 by ursodeoxycholic acid (UDCA) in primary sclerosing cholangitis (PSC).
by: Mitchell, SA, et al.
Published: (1997)

Cigarette smoking, appendectomy and tonsillectomy as risk factors for the development of primary sclerosing cholangitis (PSC): A case control study.
by: Mitchell, SA, et al.
Published: (1998)

Diagnosis and management of primary sclerosing cholangitis.
by: Chapman, R, et al.
Published: (2010)

Primary sclerosing cholangitis.
by: Mitchell, SA, et al.
Published: (2000)

Detection of antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: a comparison of the alkaline phosphatase and immunofluorescent techniques.
by: Bansi, D, et al.
Published: (1997)

INTERFERON-GAMMA PRODUCTION IN PRIMARY SCLEROSING CHOLANGITIS
by: Martins, E, et al.
Published: (1995)

Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
by: Chapman, R
Published: (2010)

Time-dependent Cox regression model is superior in prediction of prognosis in primary sclerosing cholangitis.
by: Boberg, K, et al.
Published: (2002)

Sclerosing cholangitis
by: Martins, E, et al.
Published: (1998)

Sclerosing cholangitis
by: Martins, E, et al.
Published: (1997)

Sclerosing cholangitis.
by: Björnsson, E, et al.
Published: (2003)

Sclerosing cholangitis.
by: Martins, E, et al.
Published: (2001)

Sclerosing cholangitis.
by: Martins, E, et al.
Published: (1999)

Sclerosing cholangitis.
by: Martins, E, et al.
Published: (2000)

SCLEROSING CHOLANGITIS
by: Martins, E, et al.
Published: (1995)

Sclerosing cholangitis
by: Martins, E, et al.
Published: (1996)

Characterization of the antigen for the antineutrophil cytoplasmic antibody specific for primary sclerosing cholangitis (PSC) ulcerative colitis (UC).
by: Cameron, B, et al.
Published: (1998)